Latest news
Loading news…
Syremis Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Tel Aviv, Israel Founded 2025 11-50 employees For Profit
Syremis Therapeutics is developing novel medicines to make a profound impact on the treatment of mental health disorders.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
7
3 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 7
- Trademarks
- 3
- Top patent class
- Organic Chemistry
Company Info
- Founded
- 2025
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 14
- HQ
- Tel Aviv, Israel
- Region
- Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- 6.9
- Trend (90d)
- 5.7
- Last leadership hire
- Jun 16, 2026
Key People at Syremis Therapeutics
Chief Medical Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Syremis Therapeutics
Loading news…
FAQs about Syremis Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.